India Contraceptive Devices Market Report 2022 to 2030

India Contraceptive Devices Market Analysis

$ 3999

India's Contraceptive Devices Market is expected to witness growth from $235 Mn in 2022 to $541 Mn in 2030 with a CAGR of 11.00% for the forecasted year 2022-30. The need for family planning methods is growing as India's population expands. This is increasing demand for contraceptive methods because they are a secure and reliable way to avoid unplanned pregnancies. The market is segmented by type and by gender. Some key players in this market include HLL Lifecare, Xian Janssen Pharmaceutical, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, Pregna International and Teva Pharmaceutical.

ID: IN10INMD005 CATEGORY: Medical Devices GEOGRAPHY: India AUTHOR: Jigyasu Bhandari

Buy Now

India Contraceptive Devices Healthcare Market Executive Analysis

India's Contraceptive Devices Market is expected to witness growth from $235 Mn in 2022 to $541 Mn in 2030 with a CAGR of 11.00% for the forecasted year 2022-30. The astounding $10.75 billion set aside for health expenses in India's Union Budget for 2023 marks an increase of $0.28 billion (or 2.71%) from the $10.47 billion set aside in FY23. The anticipated budget for the Ministry of Health for 2022–2023 was originally $10.42 billion but was later reduced to $9.57 billion for the same period. Estimates place the value of investments at $10.78 billion this year. In India, the budget allocation for healthcare dropped from 2.2% to 1.97% this year.

In India in 2021, 35,000 women lost their lives during pregnancy or childbirth. In comparison to the global average of 211 per 100,000 live births, India's maternal mortality ratio in 2020 was 113 per 100,000 live births. In India, 2.14 million persons with HIV as of 2021. In India, the prevalence of HIV among adults (15–49 years) was 0.29 per cent, which is lower than the 0.11 per cent global average. India has a large population, thus there are still a large number of people there who are HIV-positive. Contraceptive methods, such as hormonal implants, contraceptive patches, and intrauterine devices, are quite effective at preventing unplanned births. These techniques can have a less than 1% failure rate when implemented properly. By enabling women to plan and spread out their pregnancies, contraceptive methods provide them with more control over their reproductive health. By lowering the risk of problems during pregnancy and childbirth, can enhance outcomes for mother and child health. Additionally, contraceptive methods can aid in the prevention of HIV/AIDS and other STDs. For instance, condoms are a successful way of both STI protection and contraception. When compared to other methods of family planning like sterilisation or the use of oral contraceptives, contraceptive devices can be a more affordable option.

India Contraceptive Devices Market Analysis

Market Dynamics

Market Growth Drivers

The need for family planning methods is growing as India's population expands. This is increasing demand for contraceptive methods because they are a secure and reliable way to avoid unplanned pregnancies. India is becoming more and more aware of the significance of sexual and reproductive health, especially among women. This is increasing the need for family planning services and contraceptives. The Indian government has put in place a number of programmes to encourage family planning and widen access to contraceptive methods. For instance, the National Family Planning Programme offers qualified couples free contraceptives.

Market Restraints

The availability of healthcare services varies widely across India, especially in rural areas. This may restrict access to family planning services and contraceptives, especially for vulnerable people. The use of contraceptive methods is restricted in various areas of India due to cultural and social issues. Among them include the shame associated with family planning and the demand for large families. In some areas of India, especially among women, there is a lack of knowledge and instruction regarding sexual and reproductive health. This may reduce the demand for family planning services and contraceptive methods.

Competitive Landscape

Key Players

HLL Lifecare (IN)
Mankind Pharma (IN)
Xian Janssen Pharmaceutical
Mylan Laboratories
Church & Dwight
CooperSurgical
Pfizer
Pregna International
Teva Pharmaceutical

Recent Notable Deals

March 2023: Reckitt Benckiser Group, based in Mumbai, sold its contraception division to Mankind Pharma for $13 million in 2023. Through this agreement, Mankind Pharma gained access to a variety of contraceptives, including the well-known Durex brand.

December 2022: In 2022, HLL Lifecare Limited and the government of Mozambique struck an agreement for the company to export condoms to that country. For HLL, the sale is anticipated to bring in around $13 million in income.

Healthcare Policies and Regulatory Landscape

The registration, import, production, and sale of contraceptive devices in India are regulated by a series of laws known as the Medical Devices Rules, 2017. The main law governing the production, import, distribution, and sale of medicines and medical equipment in India, including contraceptive equipment, is the Drugs and Cosmetics Act, of 1940. The National Family Planning Programme is a government-run initiative that strives to give all Indian residents access to family planning services and contraceptives. A variety of family planning tools are available through the programme, including tablets, condoms, IUDs, and surgical sterilisation. In India, pregnancies may be terminated under the Medical Termination of Pregnancy Act, of 1971. Subject to a few restrictions, the law permits the termination of pregnancies up to 20 weeks.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

India Contraceptive Devices Market Segmentation

By Type (Revenue, USD Billion):

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS, per the World Health Organization Updates in November 2020. To a lesser extent, they also protect against genital herpes, human papillomavirus (HPV), and syphilis. Hence, the other reasons that aid the growth of the contraception devices market are the rising occurrence of STDs and the substantial increase in the population

Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
Intra Uterine Devices (IUD)
Other Devices

By Gender (Revenue, USD Billion):

Based on Gender the contraceptive devices market is segmented into male and female.

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.